Connect Biopharma Holdings Ltd. (CNTB)
0.7287
0.00 (0.00%)
USD |
NASDAQ |
Nov 06, 16:00
0.73
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Total Long Term Debt (Quarterly) : 0.203M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.203M |
| March 31, 2026 | 0.287M |
| December 31, 2025 | 0.368M |
| Date | Value |
|---|---|
| September 30, 2025 | 0.445M |
| June 30, 2025 | 0.52M |
| March 31, 2025 | 0.594M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 0.00 |
| Vaxcyte, Inc. | 215.14M |
| Foghorn Therapeutics, Inc. | 40.28M |
| Caribou Biosciences, Inc. | 24.88M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |